Annual FCF
-$23.35 M
+$90.69 M+79.53%
December 31, 2023
Summary
- As of February 22, 2025, ACAD annual free cash flow is -$23.35 million, with the most recent change of +$90.69 million (+79.53%) on December 31, 2023.
- During the last 3 years, ACAD annual FCF has risen by +$120.41 million (+83.76%).
- ACAD annual FCF is now -192.18% below its all-time high of $25.33 million, reached on December 31, 2000.
Performance
ACAD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$63.18 M
+$38.16 M+152.57%
September 30, 2024
Summary
- As of February 22, 2025, ACAD quarterly free cash flow is $63.18 million, with the most recent change of +$38.16 million (+152.57%) on September 30, 2024.
- Over the past year, ACAD quarterly FCF has increased by +$122.18 million (+207.07%).
- ACAD quarterly FCF is now -26.01% below its all-time high of $85.39 million, reached on December 31, 2023.
Performance
ACAD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$202.66 M
+$122.18 M+151.82%
September 30, 2024
Summary
- As of February 22, 2025, ACAD TTM free cash flow is $202.66 million, with the most recent change of +$122.18 million (+151.82%) on September 30, 2024.
- Over the past year, ACAD TTM FCF has increased by +$335.25 million (+252.84%).
- ACAD TTM FCF is now at all-time high.
Performance
ACAD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ACAD Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +79.5% | +207.1% | +252.8% |
| 3 y3 years | +83.8% | +470.2% | +252.2% |
| 5 y5 years | +86.2% | +433.7% | +233.1% |
ACAD Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +81.6% | -26.0% | +182.8% | at high | +242.8% |
| 5 y | 5-year | at high | +84.7% | -26.0% | +182.8% | at high | +230.7% |
| alltime | all time | -192.2% | +89.3% | -26.0% | +182.8% | at high | +181.0% |
ACADIA Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $63.18 M(+152.6%) | $202.66 M(+151.8%) |
| Jun 2024 | - | $25.01 M(-14.0%) | $80.48 M(+240.1%) |
| Mar 2024 | - | $29.08 M(-65.9%) | $23.66 M(-201.4%) |
| Dec 2023 | -$23.35 M(-79.5%) | $85.39 M(-244.7%) | -$23.35 M(-82.4%) |
| Sep 2023 | - | -$59.01 M(+85.6%) | -$132.59 M(+78.4%) |
| Jun 2023 | - | -$31.80 M(+77.3%) | -$74.31 M(+33.6%) |
| Mar 2023 | - | -$17.93 M(-24.8%) | -$55.64 M(-51.2%) |
| Dec 2022 | -$114.03 M(-10.1%) | -$23.85 M(+3181.2%) | -$114.03 M(+0.6%) |
| Sep 2022 | - | -$727.00 K(-94.5%) | -$113.30 M(-12.6%) |
| Jun 2022 | - | -$13.13 M(-82.8%) | -$129.64 M(-8.6%) |
| Mar 2022 | - | -$76.33 M(+230.1%) | -$141.89 M(+11.9%) |
| Dec 2021 | -$126.78 M(-11.8%) | -$23.12 M(+35.5%) | -$126.78 M(-4.8%) |
| Sep 2021 | - | -$17.06 M(-32.7%) | -$133.15 M(-5.3%) |
| Jun 2021 | - | -$25.37 M(-58.6%) | -$140.60 M(-9.3%) |
| Mar 2021 | - | -$61.23 M(+107.6%) | -$155.04 M(+7.9%) |
| Dec 2020 | -$143.75 M(-5.6%) | -$29.49 M(+20.3%) | -$143.75 M(-0.3%) |
| Sep 2020 | - | -$24.51 M(-38.4%) | -$144.18 M(+4.0%) |
| Jun 2020 | - | -$39.82 M(-20.3%) | -$138.60 M(+1.0%) |
| Mar 2020 | - | -$49.94 M(+66.9%) | -$137.20 M(-9.9%) |
| Dec 2019 | -$152.26 M(-10.2%) | -$29.91 M(+58.0%) | -$152.26 M(-6.0%) |
| Sep 2019 | - | -$18.93 M(-50.7%) | -$161.95 M(-13.1%) |
| Jun 2019 | - | -$38.42 M(-40.9%) | -$186.31 M(-1.4%) |
| Mar 2019 | - | -$65.00 M(+64.1%) | -$188.89 M(+11.4%) |
| Dec 2018 | -$169.57 M(-22.4%) | -$39.60 M(-8.5%) | -$169.57 M(+6.1%) |
| Sep 2018 | - | -$43.30 M(+5.6%) | -$159.87 M(-8.7%) |
| Jun 2018 | - | -$40.99 M(-10.3%) | -$175.03 M(-9.4%) |
| Mar 2018 | - | -$45.68 M(+52.8%) | -$193.21 M(-11.6%) |
| Dec 2017 | -$218.57 M(+0.3%) | -$29.90 M(-48.8%) | -$218.57 M(-12.6%) |
| Sep 2017 | - | -$58.46 M(-1.2%) | -$250.10 M(+3.6%) |
| Jun 2017 | - | -$59.16 M(-16.7%) | -$241.38 M(-2.5%) |
| Mar 2017 | - | -$71.05 M(+15.6%) | -$247.54 M(+13.6%) |
| Dec 2016 | -$217.91 M(+75.8%) | -$61.44 M(+23.5%) | -$217.91 M(+13.8%) |
| Sep 2016 | - | -$49.73 M(-23.9%) | -$191.49 M(+10.2%) |
| Jun 2016 | - | -$65.33 M(+57.7%) | -$173.80 M(+25.0%) |
| Mar 2016 | - | -$41.42 M(+18.3%) | -$139.02 M(+12.2%) |
| Dec 2015 | -$123.94 M(+86.1%) | -$35.02 M(+9.3%) | -$123.94 M(+16.0%) |
| Sep 2015 | - | -$32.04 M(+4.9%) | -$106.82 M(+15.7%) |
| Jun 2015 | - | -$30.55 M(+16.0%) | -$92.34 M(+17.2%) |
| Mar 2015 | - | -$26.33 M(+47.2%) | -$78.76 M(+18.2%) |
| Dec 2014 | -$66.61 M(+105.7%) | -$17.89 M(+1.9%) | -$66.61 M(+12.7%) |
| Sep 2014 | - | -$17.56 M(+3.5%) | -$59.11 M(+14.9%) |
| Jun 2014 | - | -$16.97 M(+19.6%) | -$51.44 M(+28.6%) |
| Mar 2014 | - | -$14.19 M(+36.5%) | -$39.99 M(+23.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$32.39 M(+49.7%) | -$10.39 M(+5.1%) | -$32.39 M(+14.5%) |
| Sep 2013 | - | -$9.89 M(+79.2%) | -$28.29 M(+19.3%) |
| Jun 2013 | - | -$5.52 M(-16.2%) | -$23.71 M(+3.1%) |
| Mar 2013 | - | -$6.58 M(+4.6%) | -$22.99 M(+6.3%) |
| Dec 2012 | -$21.63 M(+8.7%) | -$6.30 M(+18.7%) | -$21.63 M(+4.6%) |
| Sep 2012 | - | -$5.31 M(+10.5%) | -$20.67 M(+5.8%) |
| Jun 2012 | - | -$4.80 M(-8.2%) | -$19.54 M(-2.4%) |
| Mar 2012 | - | -$5.23 M(-2.0%) | -$20.02 M(+0.6%) |
| Dec 2011 | -$19.90 M(+85.9%) | -$5.34 M(+27.9%) | -$19.90 M(+99.8%) |
| Sep 2011 | - | -$4.17 M(-20.9%) | -$9.96 M(+19.9%) |
| Jun 2011 | - | -$5.28 M(+3.4%) | -$8.30 M(-11.3%) |
| Mar 2011 | - | -$5.11 M(-210.9%) | -$9.36 M(-12.6%) |
| Dec 2010 | -$10.70 M(-22.3%) | $4.60 M(-282.6%) | -$10.70 M(-55.6%) |
| Sep 2010 | - | -$2.52 M(-60.2%) | -$24.10 M(-27.5%) |
| Jun 2010 | - | -$6.33 M(-1.8%) | -$33.25 M(+380.0%) |
| Mar 2010 | - | -$6.45 M(-26.6%) | -$6.93 M(-49.7%) |
| Dec 2009 | -$13.77 M(-78.8%) | -$8.79 M(-24.7%) | -$13.77 M(-20.2%) |
| Sep 2009 | - | -$11.68 M(-158.4%) | -$17.26 M(-19.7%) |
| Jun 2009 | - | $19.99 M(-250.4%) | -$21.49 M(-62.8%) |
| Mar 2009 | - | -$13.29 M(+8.3%) | -$57.76 M(-11.3%) |
| Dec 2008 | -$65.09 M(+17.6%) | -$12.28 M(-22.8%) | -$65.09 M(-2.5%) |
| Sep 2008 | - | -$15.91 M(-2.3%) | -$66.75 M(+4.1%) |
| Jun 2008 | - | -$16.28 M(-21.1%) | -$64.14 M(+4.0%) |
| Mar 2008 | - | -$20.62 M(+48.0%) | -$61.67 M(+11.4%) |
| Dec 2007 | -$55.34 M(+27.4%) | -$13.93 M(+4.8%) | -$55.34 M(+1.3%) |
| Sep 2007 | - | -$13.30 M(-3.8%) | -$54.63 M(+1.4%) |
| Jun 2007 | - | -$13.82 M(-3.3%) | -$53.86 M(+8.6%) |
| Mar 2007 | - | -$14.29 M(+8.1%) | -$49.57 M(+14.1%) |
| Dec 2006 | -$43.44 M(+104.1%) | -$13.22 M(+5.5%) | -$43.44 M(+15.9%) |
| Sep 2006 | - | -$12.53 M(+31.4%) | -$37.49 M(+18.9%) |
| Jun 2006 | - | -$9.53 M(+16.8%) | -$31.54 M(+8.4%) |
| Mar 2006 | - | -$8.16 M(+12.4%) | -$29.09 M(+36.7%) |
| Dec 2005 | -$21.29 M(+0.0%) | -$7.26 M(+10.5%) | -$21.29 M(+1.7%) |
| Sep 2005 | - | -$6.58 M(-7.2%) | -$20.92 M(+6.7%) |
| Jun 2005 | - | -$7.08 M(+1873.5%) | -$19.62 M(+10.9%) |
| Mar 2005 | - | -$359.00 K(-94.8%) | -$17.69 M(-16.9%) |
| Dec 2004 | -$21.28 M(+83.5%) | -$6.90 M(+31.0%) | -$21.28 M(+48.0%) |
| Sep 2004 | - | -$5.27 M(+2.2%) | -$14.38 M(+57.9%) |
| Jun 2004 | - | -$5.16 M(+30.8%) | -$9.10 M(+130.8%) |
| Mar 2004 | - | -$3.94 M | -$3.94 M |
| Dec 2003 | -$11.59 M(+20.5%) | - | - |
| Dec 2002 | -$9.62 M(-138.0%) | - | - |
| Dec 2000 | $25.33 M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual FCF year-on-year change?
- What is ACADIA Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly FCF year-on-year change?
- What is ACADIA Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM FCF year-on-year change?
What is ACADIA Pharmaceuticals annual free cash flow?
The current annual FCF of ACAD is -$23.35 M
What is the all time high annual FCF for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual free cash flow is $25.33 M
What is ACADIA Pharmaceuticals annual FCF year-on-year change?
Over the past year, ACAD annual free cash flow has changed by +$90.69 M (+79.53%)
What is ACADIA Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of ACAD is $63.18 M
What is the all time high quarterly FCF for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly free cash flow is $85.39 M
What is ACADIA Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, ACAD quarterly free cash flow has changed by +$122.18 M (+207.07%)
What is ACADIA Pharmaceuticals TTM free cash flow?
The current TTM FCF of ACAD is $202.66 M
What is the all time high TTM FCF for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM free cash flow is $202.66 M
What is ACADIA Pharmaceuticals TTM FCF year-on-year change?
Over the past year, ACAD TTM free cash flow has changed by +$335.25 M (+252.84%)